When was SkinJect founded?

SkinJect was founded in 2015 and raised its 1st funding round within a year of its incorporation.

Where is SkinJect located?

SkinJect is headquartered in Pittsburgh, United States.

How many employees does SkinJect have?

As of Jul 01, 2024, the latest employee count at SkinJect is 2.

Is SkinJect a funded company?

SkinJect is a funded company, having raised a total of $2.5M across 4 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Dec 18, 2015.

When was the latest funding round of SkinJect?

SkinJect's latest funding was a $***** Series A round on Jul 15, 2021, with participation from 0 investor. Its primary sector is Drug Delivery. In United States, the Drug Delivery sector has seen $196M in funding in 2026 to date.

Where does SkinJect rank among its competitors?

SkinJect ranks 11th amongst 36 active competitors, of which 14 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Terrestrial, which secured $57.3M in Mar, 2026.

Who are the top competitors of SkinJect?

SkinJect's top competitors include Insulet, Eikon and Enable Injections. Among them, Terrestrial secured the most recent funding round in March, 2026.

SkinJect - 2026 Company Profile, Team, Funding & Competitors

SkinJect is a series A company based in Pittsburgh (United States), founded in 2015. It operates as a Developer of microneedle patch to treat skin cancer. SkinJect has raised $2.5M in funding. The company has 36 active competitors, including 14 funded and 5 that have exited. Its top competitors include companies like Insulet, Eikon and Enable Injections.

Company Details

Developer of microneedle patch to treat skin cancer. The company's device comprises a dissolvable microneedle array to deliver a drug directly into the top layer of the skin. It kills non-melanoma skin cancer by causing an immune system reaction to combat the disease.

Website: www.skinjectpatch.com/
Social
Email ID: *****@skinjectpatch.com
Phone Number: +1 **********

Key Metrics

Founded Year

2015

Location

Pittsburgh, United States

Stage

Series A

Total Funding

$2.5M in 4 rounds

Latest Funding Round

Series A, Jul 15, 2021, $*****

Investors

Topanga Partners & 1 more

Ranked

11^th among 36 active competitors

Employee Count

2 as on Jul 01, 2024

Similar Companies

Insulet & 37 more

View SkinJect's full profile

SkinJect has raised a total funding of $2.5M over 4 rounds. Its first funding round was on Dec 18, 2015. SkinJect has 2 institutional investors.

Here is the list of recent funding rounds of SkinJect:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 15, 2021	7572300	Series A	7498548	6063213	6113573	9832751
May 30, 2019	9836417	Series A	6542984	1067009	1130821	8856184
May 2016	2321500	Seed	5839275	1270004	3818811	Velocity Fund Partners

Access funding benchmarks and valuations. Sign up today!

View details of SkinJect's funding rounds and investors

SkinJect's employee count trend

SkinJect has 2 employees as of Jul 24. Here is SkinJect's employee count trend over the years:

Uncover SkinJect's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SkinJect include Insulet, Eikon and Enable Injections. Here is the list of Top 10 competitors of SkinJect, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	77/100
2nd	Eikon 2019, Millbrae (United States), Public	Protein tracking and measuring tool for drug discovery	$1.16B	The Column Group, Foresite Capital & 22 others	62/100
3rd	Enable Injections 2010, Cincinnati (United States), Series C	Provider of a wearable drug delivery solution	$334M	Sanofi, Magnetar & 13 others	59/100
4th	Highlight Therapeutics 2010, Paterna (Spain), Series B	Developer of RNA-based therapies for dermato-oncology conditions and skin cancers	$44.7M	Advent Life Sciences, Columbus Venture Partners ... & 5 others	55/100
5th	Micron Biomedical 2014, Atlanta (United States), Series A	Developer of microneedle patch technology for vaccines and drugs delivery	$33M	Global Health Investment, J2 Ventures & 10 others	48/100
6th	Polynoma 2007, San Diego (United States), Unfunded	Developer of drugs for treating melanoma	-	-	41/100
7th	Pokeacell 2020, Copenhagen (Denmark), Seed	Developer of T cell therapeutic solutions for cancer treatment	$1.48M	BioInnovation Institute	40/100
8th	Terrestrial 2011, Woburn (United States), Series C	Developer of a microarray patch platform for therapeutic delivery	$57.3M	RA Capital Management, Engine Ventures & 2 others	39/100
9th	OnQuality 2018, Shanghai (China), Series A	Developer of therapeutics for skin cancers	$35M	Frees Fund, Cash Capital & 5 others	39/100
10th	Zosano Pharma 2006, Fremont (United States), Deadpooled	Developer of transdermal drug delivery systems for a broad range of therapeutic indications	$147M	HBM Healthcare Investments, Nomura & 9 others	36/100
11th	SkinJect 2015, Pittsburgh (United States), Series A	Developer of microneedle patch to treat skin cancer	$2.5M	Topanga Partners, Velocity Fund Partners	34/100